comparemela.com
Home
Live Updates
Elevated PCSK9-Psoriasis Link: A New Target for Treatment? :
Elevated PCSK9-Psoriasis Link: A New Target for Treatment? :
Elevated PCSK9-Psoriasis Link: A New Target for Treatment?
The study suggests that "PCSK9 inhibition is causally associated with reduced risk of psoriasis" and has implications for prevention and possibly treatment of psoriasis, the investigators say.
Related Keywords
Finland ,
United States ,
United Kingdom ,
Manchester ,
American ,
Chugai Roche ,
Sizheng Steven Zhao ,
Michaels Garshick ,
York University Langone Health ,
Pfizer ,
American Academy Of Dermatology ,
University Of Manchester England ,
National Psoriasis Foundation ,
Bristol Myers Squibb ,
Manchester Biomedical Research Centre ,
American Academy ,
National Psoriasis ,
New York University Langone ,
Versus Arthritis ,
National Institute ,
Biomedical Research ,
Psoriasis ,
Lipids ,
Ipid Management ,
Pcsk9 ,
Roprotein Convertase Subtilisin Kexin Type 9 ,
Clinical Research ,
Clinical Trials ,
Linical Studies ,
Genetics ,
Grant ,
Cv ,
Ardiovascular ,
Arthritis ,
Oint Inflammation ,
Dyslipidemia ,
Genomics ,
Genomic Medicine ,
Edicine Genomic ,
Healthcare And Medical Technology ,
Ealth And Medical Tech ,
Ealth And Med Tech ,
Ealth And Medical Technology ,
Metabolism ,
Etabolic ,
Hat ,